SARS-CoV-2 triggered relapse of multiple sclerosis

OBJECTIVES: There are indications that SARS-CoV-2 can trigger new onset or relapses of neuro-immunological disease. We report a patient with relapsing remitting multiple sclerosis (RRMS) under disease-modifying therapy (DMT) who experienced a relapse of RRMS after mild COVID-19. CASE REPORT: The pat...

Descripción completa

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920077/
https://www.ncbi.nlm.nih.gov/pubmed/35305393
http://dx.doi.org/10.1016/j.clineuro.2022.107210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920077/
https://www.ncbi.nlm.nih.gov/pubmed/35305393
http://dx.doi.org/10.1016/j.clineuro.2022.107210

Ejemplares similares